Shock, Septic

The grounding supports septic shock as being associated with sepsis, but it does not specify a single cause or aetiologic agent. The review material also indicates that infection and microbiology are relevant to the condition, but no specific pathogens are provided. Null would be unsupported because the supplied text does not define a more precise cause.

The supplied grounding points to abnormalities in hemodynamics, immunity, and innate immune mechanisms. It also highlights cytokines and lactic acid, consistent with inflammatory dysregulation and impaired tissue perfusion in septic shock. The condition is characterized by circulatory failure with ongoing hypoperfusion despite fluid resuscitation, leading to organ dysfunction markers such as lactic acidosis and oliguria.

The supplied grounding does not identify specific patient-level risk factors for developing septic shock. It only indicates that the condition is studied in the context of sepsis, infection, and sepsis-associated organ dysfunction, including in children. No additional risk factors are supported by the provided material.

The review and guideline abstracts support management with guideline-based sepsis and septic shock therapy, organized around hemodynamics, infection, adjunctive therapies, metabolic care, and ventilation. The grounding also indicates drug therapy and therapy as major literature themes, but it does not specify individual drugs or regimens. At the modality level, standard care is therefore supportive critical care plus infection-directed treatment and hemodynamic management.